부산대학교 도서관

Edward Man-Lik Choi; Boris Lacarra; Muhammed O Afolabi; Boni Maxime Ale; Frank Baiden; Christine Bétard; Julie Foster; Benjamin Hamzé; Christine Schwimmer; Daniela Manno; Eric D’Ortenzio; David Ishola; Cheick Mohamed Keita; Babajide Keshinro; Yusupha Njie; Wim van Dijck; Auguste Gaddah; Dickson Anumendem; Brett Lowe; Renaud Vatrinet; Bolarinde Joseph Lawal; Godfrey T Otieno; Mohamed Samai; Gibrilla Fadlu Deen; Ibrahim Bob Swaray; Abu Bakarr Kamara; Michael Morlai Kamara; Mame Aminata Diagne; Dickens Kowuor; Chelsea McLean; Bailah Leigh; Abdoul Habib Beavogui; Maarten Leyssen; Kerstin Luhn; Cynthia Robinson; Macaya Douoguih; Brian Greenwood; Rodolphe Thiébaut; Deborah Watson-Jones; T Mooney; L Conteh; MS Bangura; MA Bangura; H Jalloh; I Kamara; M Kamara; S Koroma; M Sesay; MT Sesay; AT Deen; A Kamara; EL Kamara; SLM Kamara; AH Koroma; IS Mansaray; MJ Massaquoi; A Nabie; D Kowuor; Y Njie; L Odeny; M Sheku; AB Jalloh; A Sow; E Swaray; F Mansaray; T Sessie; J-HC Sunders; SI-S Turay; J Weekes; M Pessima; A Wurie; M Conteh; MI Jalloh; PBD Kamara; DP Kanneh; M Kanneh; I Komeh; M Koroma; M Kuyateh; FF Mansaray; B Leigh; D Watson-Jones; M Samai; GF Deen; T Sesay; P Piot; B Greenwood; S Lees; H Larson; M Afolabi; D Ishola; F Baiden; F Faye; D Tindanbil; MM Kamara; IB Swaray; A Bangura; AB Kamara; FE Morovia; JA Kallon; M Murray; F Sesay; F Suma; IG Sesay; EM Choi; D Manno; J Foster; R Rwezaula; I Akhigbe; H Adetola; B Kamara; B Lowe; B Lawal; B Kohn; GO Tuda; F Koroma; G Bangura; MT Kroma; L Fofanah; A Pessima; M Rogers; O Sheriff; J Fangawa; S Foday; I Jabbie; HA Mansaray; K Sesay; HB Jakema; MF Sheku; KFN Jalloh; M Kabba; F Kanjie; AP Kanu; G Kassa-Koroma; M Jusu; B Koroma; P Borboh; A Kallon; K van Roey; P Conteh; M Samura; V Gandie; M Marrah; J Kalokoh; MI Bangura; N Connor; S Saidu; AS Turay; A Lahai; CL Johnson; DB Kogba; W Vincent; M Bangura; A Tengbeh; K Bangura; R Kabia; AM Nyakoi; S Lee; D Nyaberi; S Ndingi; L Nyallay; AR Bangura; B Idriss; M Sillah; W Mackay; T Murray; J Edem-Hotah; T Fatorma; S Bangura; E Bonnie; M Sannoh; S Malcolm; J Brown; E Snowden; K Howard; A Ojugo; C Massin-Shepherd; AH BEAVOGUI; CM KEITA; OK CAMARA; JPY GUILAVOGUI; H BAH; MA SAMOURA; D MUAMBA; B SEMAKUBA; AK CAMARA; AS KABA; M BERERD-CAMARA; M YARADOUNO; M DECHENAUD; MT CAMARA; J TAMBALOU; M HABA; SD DIALLO; A THEA; N DOUMBOUYA; ML FOFANA; M BEAVOGUI; AA CAMARA; JT BEAVOGUI; W DIOUF; A AUGIER; E BARTE DE SAINTE FARE; B SIVAHERA MUYISA; S SANI; R VATRINET; B HAMZE; B LACARRA; E D’ORTENZIO; B ALE; C BETARD; L RICHERT; D OULAI; M KANTE; A-A SOUTTHIPHONG; C SCHWIMMER; R THIÉBAUT; A OTTAVI; S COUFFIN-CADIERGUES; H ESPEROU; SP Chai; W Buth; K Offergeld; A Menten; N Hammoud; S De Ridder; R Sellecchia; R in ’t Veld; N Fogap; D Anumendem; H Stapleton; T Reijns; J Haydon; L Roza; B Sawyer; S Hoda; J Yee; T De Cnodder; E Hubin; L Telen; J Desai; M Bennet; M Pawlowski; N van Gils; N Boeykens; A Kwasniak; M Ligthart; G Van Roey; E Fernandez; A Gaddah; W van Dijck; S Jingshuang; S Randrasana; C Artis; A Akinbinu; A Poretti; S Van Ballaert; M Harris; M Van Looveren; P Brandt; C Robinson; V Bockstal; C McLean; I Versteege; C Ferrault; A Kaminski; H Vergauwen; CI Kerama; CA Forcheh; CV DiMondi; L Stewart; J Meurer; A Beounitis; J Peeters; C Su; B Keshinro; C Delport; E Sharkie; J Zhang; C Du; K Hu; A Strydom; I Bezem-Aviv; A Wachnicka; P Kumar; S Cheng; K Kang

The Lancet Global Health. 11:e1743-e1752

Wiedemann A; Vaccine Research Institute, Université Paris-Est, Créteil, France.; INSERM U955, Institut Mondor de Recherche Biomedicale (IMRB), Team Lévy, Créteil, France.; Lhomme E; Vaccine Research Institute, Université Paris-Est, Créteil, France.; Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, Bordeaux, France.; Univ. Bordeaux, Inserm, Population Health Research Center, UMR 1219, INRIA SISTM, Bordeaux, France.; Huchon M; Vaccine Research Institute, Université Paris-Est, Créteil, France.; Univ. Bordeaux, Inserm, Population Health Research Center, UMR 1219, INRIA SISTM, Bordeaux, France.; Foucat E; Vaccine Research Institute, Université Paris-Est, Créteil, France.; INSERM U955, Institut Mondor de Recherche Biomedicale (IMRB), Team Lévy, Créteil, France.; Bérerd-Camara M; Alliance for International Medical Action, Dakar, Senegal.; Guillaumat L; Vaccine Research Institute, Université Paris-Est, Créteil, France.; INSERM U955, Institut Mondor de Recherche Biomedicale (IMRB), Team Lévy, Créteil, France.; Yaradouno M; Alliance for International Medical Action, Dakar, Senegal.; Tambalou J; Alliance for International Medical Action, Dakar, Senegal.; Rodrigues C; Vaccine Research Institute, Université Paris-Est, Créteil, France.; INSERM U955, Institut Mondor de Recherche Biomedicale (IMRB), Team Lévy, Créteil, France.; Ribeiro A; Vaccine Research Institute, Université Paris-Est, Créteil, France.; INSERM U955, Institut Mondor de Recherche Biomedicale (IMRB), Team Lévy, Créteil, France.; Béavogui AH; Centre National de Formation et de Recherche en Santé Rurale (CNFRSR), Maferinyah, Guinea.; Lacabaratz C; Vaccine Research Institute, Université Paris-Est, Créteil, France.; INSERM U955, Institut Mondor de Recherche Biomedicale (IMRB), Team Lévy, Créteil, France.; Thiébaut R; Vaccine Research Institute, Université Paris-Est, Créteil, France.; Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, Bordeaux, France.; Univ. Bordeaux, Inserm, Population Health Research Center, UMR 1219, INRIA SISTM, Bordeaux, France.; Richert L; Vaccine Research Institute, Université Paris-Est, Créteil, France.; Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Euclid/F-CRIN clinical trials platform, Bordeaux, France.; Univ. Bordeaux, Inserm, Population Health Research Center, UMR 1219, INRIA SISTM, Bordeaux, France.; Lévy Y; Vaccine Research Institute, Université Paris-Est, Créteil, France. yves.levy@aphp.fr.; INSERM U955, Institut Mondor de Recherche Biomedicale (IMRB), Team Lévy, Créteil, France. yves.levy@aphp.fr.; Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, Service Immunologie Clinique, Créteil, France. yves.levy@aphp.fr.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Valayer S; Infection, Antimicrobials, Modelling, Evolution (IAME), Université Sorbonne Paris Nord, Paris, France; Université Sorbonne Paris Cité, Institut national de la santé et de la recherche médicale (Inserm), Paris, France; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Alexandre M; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; Prague M; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale (CNFRSR) de Mafèrinyah, Ministère de la Santé et de l'Hygiène Publique Mafèrinyah, Guinea.; Doumbia S; University Clinical Research Center, University of Sciences, Technique and Technology of Bamako, Bamako, Mali.; Kieh M; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.; Greenwood B; London School of Hygiene & Tropical Medicine (LSHTM), London, UK.; Leigh B; College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.; Poupelin M; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Schwimmer C; European Clinical Trials Platform & Development (EUCLID), Université de Bordeaux, Centre Hospitalier Universitaire Bordeaux, and Inserm, ISPED, Bordeaux, France.; Sow SO; Centre pour le Développement des Vaccins, Ministère de la Santé et du Développement Social du Mali, Bamako, Mali.; Berry IM; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, MD, USA.; Kuhn JH; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Frederick, MD, USA.; Fusco D; French Agency for Research on AIDS and Viral Hepatitis (ANRS), Emerging Infectious Diseases, PariSanté Campus, Paris, France.; Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Cauwelaert ND; Inserm, Cedex 13, Paris, France.; Watson-Jones D; London School of Hygiene & Tropical Medicine (LSHTM), London, UK.; Thiébaut R; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; European Clinical Trials Platform & Development (EUCLID), Université de Bordeaux, Centre Hospitalier Universitaire Bordeaux, and Inserm, ISPED, Bordeaux, France.; Pôle de Santé Publique, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.; Lévy Y; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; Inserm, Cedex 13, Paris, France.; Service d'Immunologie Clinique et Maladies Infectieuses, Hôpital Henri-Mondor, Créteil, France.; Yazdanpanah Y; Infection, Antimicrobials, Modelling, Evolution (IAME), Université Sorbonne Paris Nord, Université Sorbonne Paris Cité, and Institut national de la santé et de la recherche médicale (Inserm), Paris, France.; Inserm, Cedex 13, Paris, France.; Service de Maladies Infectieuses et Tropicales, Hôpital Bichat, Paris, France.; Richert L; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; European Clinical Trials Platform & Development (EUCLID), Université de Bordeaux, Centre Hospitalier Universitaire Bordeaux, and Inserm, ISPED, Bordeaux, France.; Pôle de Santé Publique, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.; Lhomme E; Bordeaux Population Health Research Centre, Université de Bordeaux, Inserm, and Inria, Bordeaux, France.; Vaccine Research Institute, Faculté de Médicine, Université Paris-Est Créteil, Créteil, France.; European Clinical Trials Platform & Development (EUCLID), Université de Bordeaux, Bordeaux, France.; Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.; Pôle de Santé Publique, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.; SISTM Team - Inserm U1219 Bordeaux, 146 Rue Léo Saignat, 33000, Bordeaux, France.; edouard.lhomme@u-bordeaux.fr.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101594885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2222-1751 (Electronic) Linking ISSN: 22221751 NLM ISO Abbreviation: Emerg Microbes Infect Subsets: MEDLINE

Lee AW; Merck & Co., Inc., Rahway, New Jersey, USA.; Liu K; Merck & Co., Inc., Rahway, New Jersey, USA.; Lhomme E; Inserm, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, University of Bordeaux, Bordeaux, France.; Blie J; Partnership for Research on Ebola Vaccines in Liberia (PREVAIL), Monrovia, Liberia.; McCullough J; Advanced BioMedical Laboratories (ABML), Cinnaminson, New Jersey, USA.; Onorato MT; Merck & Co., Inc., Rahway, New Jersey, USA.; Connor L; Merck & Co., Inc., Rahway, New Jersey, USA.; Simon JK; Merck & Co., Inc., Rahway, New Jersey, USA.; Dubey S; Merck & Co., Inc., Rahway, New Jersey, USA.; VanRheenen S; Merck & Co., Inc., Rahway, New Jersey, USA.; Deutsch J; Merck & Co., Inc., Rahway, New Jersey, USA.; Owens A; Merck & Co., Inc., Rahway, New Jersey, USA.; Morgan A; Merck & Co., Inc., Rahway, New Jersey, USA.; Welebob C; Merck & Co., Inc., Rahway, New Jersey, USA.; Hyatt D; Merck & Co., Inc., Rahway, New Jersey, USA.; Nair S; Merck & Co., Inc., Rahway, New Jersey, USA.; Hamzé B; Pôle Recherche Clinique, Institut National de la Santé et de la Recherche Médicale (Inserm), Paris, France.; Guindo O; University Clinical Research Center (UCRC), Bamako, Mali.; Sow SO; CVD-Mali, Bamako, Mali.; Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale (CNFRSR), Maferinyah, Guinea.; Leigh B; College of Medicine & Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.; Samai M; College of Medicine & Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.; Akoo P; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.; Serry-Bangura A; College of Medicine & Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.; Fleck S; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.; Secka F; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.; Lowe B; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.; Watson-Jones D; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine (LSHTM), London, United Kingdom.; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.; Roy C; Inserm, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, University of Bordeaux, Bordeaux, France.; University of Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France.; Hensley LE; National Bio and Agro-Defense Facility (NBAF), United States Department of Agriculture (USDA), Manhattan, Kansas, USA.; Kieh M; Partnership for Research on Ebola Vaccines in Liberia (PREVAIL), Monrovia, Liberia.; Coller BG; Merck & Co., Inc., Rahway, New Jersey, USA.

Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Badio, M.; Kieh, M.; Kennedy, S.B.; Roy, C.; Chêne, G.; Richert, L.; Lhomme, E.; Termote, M.; Beavogui, A.H.; Doumbia, S.; Leigh, B.; Sow, S.O.; Diallo, A.; Fusco, D.; Esperou, H.; Kirchoff, M.; Lane, H.C.; Pierson, J.; Vatrinet, R.; D’Ortenzio, E.; Yazdanpanah, Y.; Wentworth, D.; Neaton, J.D.; Watson-Jones, D.; Greenwood, B.; Abdoulaye, C.; Aboulhab, J.; Akoo, P.; Akpa, E.; Akpata, R.; Albert, S.; Ale, B.M.; C. Andrews, B.; Anoma, S.; Assiandi, S.-S.; Augier, A.; Awuondo, K.; Bagayoko, A.; Bakare, N.; Balde, A.; Bangura, L.M.; Barrington, K.; Barte de Saint Fare, E.; Baseler, B.; Bauder, A.; Bauduin, C.; Bawo, L.; Habib Beavogui, A.; Belson, M.; Bererd, M.; Beyslow, T.; Binachon, B.; Blie, J.; Bockstal, V.; Boire, Y.; Boison, P.; Bolay, F.; Boly, A.; Gael Borg, A.; Bowers, D.; Browne, S.; Cagniard, B.; Cahill, K.; Abdoulaye Camara, A.; Camara, K.; Camara, M.; Campion, C.; Cash, J.; Pin Chai, S.; Chambelin, F.; Chieck, K.; Ciancia, S.; Ndiaga Cisse, P.; Clide, E.; Colin, C.; Coller, B.-A.; Siaka Conde, D.; Cone, K.; Connor, L.; Connor, N.; Boye Cooper, J.; Couffin-Cardiergues, S.; Coulibaly, F.; Coulibaly, M.; Dabakuyo-Yonli, S.; Dabitao, D.; Damerval, T.; Davis, B.; Fadlu Deen, G.; Dekeyster, E.; Delfraissy, J.-F.; Delmas, C.; Dembele, R.; Diakite, M.; Saliou Diallo, M.; Diarra, A.; Diawara, O.; Dighero-kemp, B.; Diop, S.; Diouf, W.; Doepel, L.; Moise Doumbia, M.; Douoguih, M.; DuChêne, A.; Duvenhage, M.; Eckes, R.E.; Egan, A.; Enria, L.; Espérou, H.; Etienne, C.; Eyler, A.; Faye, S.; Fernandez, J.; Fleck, S.; Fofana, V.; Franklin, K.; Gaddah, A.; Gaignet, M.; Gallagher, K.; Garcia Gozalbes, J.; Grandits, G.; Gray, M.; Greijer, A.; Grue, L.; Grund, B.; Guindo, O.; Gupta, S.; Haidara, F.; Hamze, B.; Hancox, E.; Hart, G.; Hébert, J.-C.; Heijnen, E.; Hensley, P.; Hensley, L.; Higgs, E.; Hilton, T.; Holley, P.; Hoover, M.; Howard, N.; Hughes, M.; Ilo, D.; Imes, J.; Irvine, S.; Ishola, D.; Jacob, W.; Jato, Y.; Johnson, M.; Jusu, M.; Sidiki Kaba, A.; Kante, M.; Katoudi, J.; Keita, S.; Kennedy, S.; Jide Keshinro, B.; Khon, B.; Kiawu, H.; Kirchoff, M.; Kodio, M.; Koivogui, L.; Kombi, T.; Kopka, S.; Kowuors, D.; Lacabaratz, C.; Lacarra, B.; Lambert, L.; Lane, C.; Lee, S.; Lees, S.; Lefevre, A.; Lemarcis, F.; Lévy, Y.; Levy-Marchal, C.; Lewally, J.; Leyssen, M.; Liu, K.; Lowe, B.; Lysander, J.; Madelaine, C.; Mahamadou, I.; Manno, D.; Marchand, J.; Marynissen, S.; Massaquoi, M.B.F.; Masson, L.; Matard, C.; Matthew, O.; McCullough, J.; Mercier, N.; Michavila, P.; Miller, T.; Miranda, A.; Mohamed, S.; Mooney, T.; Morsch, H.; Muamba, D.; Lukoo Ndamenyaa, R.; Neaton, J.; Neboua, D.; Nelson, M.; Newell, K.; Nguyen, V.-K.; Nielsen, L.; Niouma, M.; Offergeld, K.; Onorato, M.; Onwuchekwa, U.; Orsega, S.; Ortega-Perez, I.; Osborne, C.; Otieno, T.; Patel, S.; Peiffer-Smadj, N.; Phillips, R.; Piot, P.; Piziali, M.; Pong, S.; Proffitt, C.; Quach, A.; Ramers-verhoeven, C.; Randunu, N.; Rivière, P.; Robinson, C.; Van Roey, G.; Falk Russell, A.; Samai, Sibiry Samake, M.; Sangare, B.; Sanogo, I.; Sadio Sarro, Y.; Sarro, S.; Saville, M.; Sawadogo, S.; Schvartz, M.; Schwimmer, C.; Secka, F.; Seraphin, J.; Shelley, D.; Siddiqui, S.; Simon, J.; Simpson, S.; Muyisa Sivahera, B.; Skip, I.; Slater, K.; Smolskis, M.; Smout, E.; Snowden, E.; Soutthiphong, A.-A.; Sow, S.; Sow, Y.; Splinter, D.; Spreng, S.; Stapleton, H.; Stoop, J.; Sweeney, M.; Tamba, S.; Tapia, M.; Tegli, J.; Thiebaut, R.; Thompson, G.; Tierney, J.; Touré, A.; Traina, S.; Traore, A.; Traore, M.; Tyee, T.; Vallée, D.; Van Der Donck, K.V.; Verbruggen, N.; Vincent, C.; Vogel, S.; Wallet, C.; Wesseh, C.; Whitworth, J.; Wiedemann, A.; Willems, W.; Williams, J.; Wilson, B.; Wissedi, N.; Wolf, J.; Woods, I.; Wurie, A.; Yamadjako, D.; Yaradouno, M.; Zeggani, Z.

In: Trials. (Trials, December 2021, 22(1))

Kieh M; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Richert L; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Beavogui AH; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Grund B; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Leigh B; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; D'Ortenzio E; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Doumbia S; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Lhomme E; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Sow S; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Vatrinet R; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Roy C; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Kennedy SB; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Faye S; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Lees S; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Millimouno NP; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Camara AM; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Samai M; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Deen GF; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Doumbia M; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Espérou H; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Pierson J; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Watson-Jones D; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Diallo A; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Wentworth D; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; McLean C; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Simon J; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Wiedemann A; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Dighero-Kemp B; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Hensley L; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Lane HC; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Levy Y; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Piot P; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Greenwood B; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Chêne G; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Neaton J; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).; Yazdanpanah Y; From the Partnership for Research on Ebola Virus in Liberia, Monrovia (M.K., S.B.K.); Unité 1219, Bordeaux Population Health, Inria, Statistics in System Biology and Translational Medicine (L.R., E.L.), Euclid-French Clinical Research Infrastructure Network Clinical Trials Platform (L.R., E.L., C.R., G.C.), University of Bordeaux, INSERM, Institut Bergonié, Centre Hospitalier Universitaire de Bordeaux, Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux (L.R., E.L., C.R., G.C.), INSERM (E.D., R.V., H.E., A.D., A.W., Y.L., Y.Y.), ANRS Emerging Infectious Diseases (France Recherche Nord&Sud Sida-HIV Hépatites) (E.D., A.D., Y.Y.), and Assistance Publique-Hôpitaux de Paris, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales (E.D., Y.Y.), Paris, and the Vaccine Research Institute, Université Paris-Est Créteil, Henri Mondor Hospital, Créteil (A.W., Y.L.) - all in France; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Maferinyah, Guinea (A.H.B.); the Schools of Public Health (D.W., J.N.) and Statistics (B. Grund), University of Minnesota, Minneapolis; the College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown (B.L., M.S., G.F.D.); University Clinical Research Center, University of Sciences, Techniques, and Technologies of Bamako (S.D.), and Centre pour le Développement des Vaccins, Ministère de la Santé (M.D.), Bamako, Mali; the Center for Vaccine Development and Global Health, University of Maryland, Baltimore (S.S.), and the National Institute of Allergy and Infectious Diseases, Bethesda (J.P., B.D.-K., L.H., H.C.L.) - both in Maryland; Département de Sociologie, Faculté des Lettres et Sciences Humaines, Université Cheikh Anta Diop (S.F.), and the Alliance for International Medical Action (N.P.M., A.M.C.) - both in Dakar, Senegal; London School of Hygiene and Tropical Medicine, London (S.L., D.W.-J., P.P., B. Greenwood); Janssen Vaccines and Prevention, Leiden, the Netherlands (C.M.); and Merck Sharp and Dohme, Kenilworth, NJ (J.S.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Sissoko D; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.; Laouenan C; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.; Folkesson E; Médecins Sans Frontières Belgique, Brussels, Belgium.; M'Lebing AB; ALIMA, Dakar, Senegal.; Beavogui AH; Centre de Recherche en Santé Rurale, Maférinya, Guinea.; Baize S; Institut Pasteur, Centre International de Recherche en Infectiologie, Lyon, France.; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.; Camara AM; Médecins Sans Frontières Belgique, Brussels, Belgium.; Maes P; European Mobile Laboratory Project, Hamburg, Germany.; Rega Institute for Medical Research, Leuven, Belgium.; Shepherd S; ALIMA, Dakar, Senegal.; Danel C; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; ALIMA, Dakar, Senegal.; Programme PACCI, Abidjan, Côte d'Ivoire.; Carazo S; Médecins Sans Frontières Belgique, Brussels, Belgium.; Conde MN; ALIMA, Dakar, Senegal.; Gala JL; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.; Colin G; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Programme PACCI, Abidjan, Côte d'Ivoire.; Croix Rouge Française, Paris, France.; Savini H; Service de Santé des Armées, Paris, France.; Bore JA; European Mobile Laboratory Project, Hamburg, Germany.; Institut National de Santé Publique, Conakry, Guinea.; Laboratoire des Fièvres Hémorragiques en Guinée, Université Gamal Abdel Nasser de Conakry, Conakry, Guinea.; Le Marcis F; Ecole Normale Supérieure, Lyon, France.; Koundouno FR; European Mobile Laboratory Project, Hamburg, Germany.; Institut National de Santé Publique, Conakry, Guinea.; Laboratoire des Fièvres Hémorragiques en Guinée, Université Gamal Abdel Nasser de Conakry, Conakry, Guinea.; Petitjean F; ALIMA, Dakar, Senegal.; Lamah MC; Médecins Sans Frontières Belgique, Brussels, Belgium.; Diederich S; European Mobile Laboratory Project, Hamburg, Germany.; Friedrich Loeffler Institute-Federal Research Institute for Animal Health, Greifswald, Germany.; Tounkara A; Médecins Sans Frontières Belgique, Brussels, Belgium.; Poelart G; Médecins Sans Frontières Belgique, Brussels, Belgium.; Berbain E; Médecins Sans Frontières Belgique, Brussels, Belgium.; Dindart JM; ALIMA, Dakar, Senegal.; Duraffour S; European Mobile Laboratory Project, Hamburg, Germany.; Rega Institute for Medical Research, Leuven, Belgium.; Lefevre A; Médecins Sans Frontières Belgique, Brussels, Belgium.; Leno T; Médecins Sans Frontières Belgique, Brussels, Belgium.; Peyrouset O; ALIMA, Dakar, Senegal.; Irenge L; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.; Bangoura N; Médecins Sans Frontières Belgique, Brussels, Belgium.; Palich R; ALIMA, Dakar, Senegal.; Hinzmann J; European Mobile Laboratory Project, Hamburg, Germany.; Robert Koch Institute, Berlin, Germany.; Kraus A; European Mobile Laboratory Project, Hamburg, Germany.; Public Health Agency of Sweden, Solna, Sweden.; Barry TS; ALIMA, Dakar, Senegal.; Berette S; ALIMA, Dakar, Senegal.; Bongono A; ALIMA, Dakar, Senegal.; Camara MS; ALIMA, Dakar, Senegal.; Chanfreau Munoz V; ALIMA, Dakar, Senegal.; Doumbouya L; ALIMA, Dakar, Senegal.; Souley Harouna; ALIMA, Dakar, Senegal.; Kighoma PM; ALIMA, Dakar, Senegal.; Koundouno FR; ALIMA, Dakar, Senegal.; Réné Lolamou; ALIMA, Dakar, Senegal.; Loua CM; ALIMA, Dakar, Senegal.; Massala V; ALIMA, Dakar, Senegal.; Moumouni K; ALIMA, Dakar, Senegal.; Provost C; ALIMA, Dakar, Senegal.; Samake N; ALIMA, Dakar, Senegal.; Sekou C; ALIMA, Dakar, Senegal.; Soumah A; ALIMA, Dakar, Senegal.; Arnould I; Médecins Sans Frontières Belgique, Brussels, Belgium.; Komano MS; Médecins Sans Frontières Belgique, Brussels, Belgium.; Gustin L; Médecins Sans Frontières Belgique, Brussels, Belgium.; Berutto C; Médecins Sans Frontières Belgique, Brussels, Belgium.; Camara D; Médecins Sans Frontières Belgique, Brussels, Belgium.; Camara FS; Médecins Sans Frontières Belgique, Brussels, Belgium.; Colpaert J; Médecins Sans Frontières Belgique, Brussels, Belgium.; Delamou L; Médecins Sans Frontières Belgique, Brussels, Belgium.; Jansson L; Médecins Sans Frontières Belgique, Brussels, Belgium.; Kourouma E; Médecins Sans Frontières Belgique, Brussels, Belgium.; Loua M; Médecins Sans Frontières Belgique, Brussels, Belgium.; Malme K; Médecins Sans Frontières Belgique, Brussels, Belgium.; Manfrin E; Médecins Sans Frontières Belgique, Brussels, Belgium.; Maomou A; Médecins Sans Frontières Belgique, Brussels, Belgium.; Milinouno A; Médecins Sans Frontières Belgique, Brussels, Belgium.; Ombelet S; Médecins Sans Frontières Belgique, Brussels, Belgium.; Sidiboun AY; Médecins Sans Frontières Belgique, Brussels, Belgium.; Verreckt I; Médecins Sans Frontières Belgique, Brussels, Belgium.; Yombouno P; Médecins Sans Frontières Belgique, Brussels, Belgium.; Bocquin A; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.; Carbonnelle C; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.; Carmoi T; Service de Santé des Armées, Paris, France.; Frange P; Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France.; Mely S; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.; Nguyen VK; Université de Montréal, Montréal, Canada.; Pannetier D; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.; Taburet AM; Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Paris, France.; Treluyer JM; Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France.; Kolie J; Centre de Recherche en Santé Rurale, Maférinya, Guinea.; Moh R; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Programme PACCI, Abidjan, Côte d'Ivoire.; Gonzalez MC; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.; Kuisma E; European Mobile Laboratory Project, Hamburg, Germany.; Public Health England, Porton Down, United Kingdom.; Liedigk B; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Ngabo D; European Mobile Laboratory Project, Hamburg, Germany.; Public Health England, Porton Down, United Kingdom.; Rudolf M; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Thom R; European Mobile Laboratory Project, Hamburg, Germany.; Public Health England, Porton Down, United Kingdom.; Kerber R; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Gabriel M; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; Di Caro A; European Mobile Laboratory Project, Hamburg, Germany.; National Institute for Infectious Diseases 'L. Spallanzani,' Rome, Italy.; Wölfel R; European Mobile Laboratory Project, Hamburg, Germany.; Bundeswehr Institute of Microbiology, Munich, Germany.; Badir J; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Bentahir M; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.; Deccache Y; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.; Dumont C; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.; Durant JF; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.; El Bakkouri K; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.; Gasasira Uwamahoro M; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.; Smits B; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Université Catholique de Louvain, Louvain-la-Neuve, Belgium.; Toufik N; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Van Cauwenberghe S; Biological Light Fieldable Laboratory for Emergencies (B-LiFE)/Belgian First Aid and Support (B-FAST), Brussels, Belgium.; Belgian Ministry of Defense, Brussels, Belgium.; Ezzedine K; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; D'Ortenzio E; Pizarro L; Solidarité Thérapeutique et Initiatives pour la Santé (Solthis), Paris, France.; Etienne A; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.; Guedj J; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.; Fizet A; Institut Pasteur, Centre International de Recherche en Infectiologie, Lyon, France.; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.; Barte de Sainte Fare E; ALIMA, Dakar, Senegal.; Murgue B; Inserm, Paris, France.; Tran-Minh T; Croix Rouge Française, Paris, France.; Rapp C; Service de Santé des Armées, Paris, France.; Piguet P; Médecins Sans Frontières Belgique, Brussels, Belgium.; Poncin M; Médecins Sans Frontières Belgique, Brussels, Belgium.; Draguez B; Médecins Sans Frontières Belgique, Brussels, Belgium.; Allaford Duverger T; ALIMA, Dakar, Senegal.; Barbe S; ALIMA, Dakar, Senegal.; Baret G; ALIMA, Dakar, Senegal.; Defourny I; ALIMA, Dakar, Senegal.; Carroll M; European Mobile Laboratory Project, Hamburg, Germany.; Public Health England, Porton Down, United Kingdom.; Southampton General Hospital, University of Southampton, Southampton, United Kingdom.; Raoul H; Inserm, Laboratoire P4 Jean Mérieux, Lyon, France.; Augier A; ALIMA, Dakar, Senegal.; Eholie SP; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Programme PACCI, Abidjan, Côte d'Ivoire.; Centre Hospitalier Universitaire de Treichville, Abidjan, Côte d'Ivoire.; Yazdanpanah Y; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.; Levy-Marchal C; Inserm, Paris, France.; Antierrens A; Médecins Sans Frontières Belgique, Brussels, Belgium.; Van Herp M; Médecins Sans Frontières Belgique, Brussels, Belgium.; Günther S; European Mobile Laboratory Project, Hamburg, Germany.; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; de Lamballerie X; Université Aix Marseille, Institut de Recherche pour le Développement, École des Hautes Études en Santé Publique, EPV, Marseille, France.; Keïta S; Cellule de Coordination Nationale de Lutte contre la Maladie à Virus Ebola, Conakry, Guinea.; Mentre F; Inserm, IAME, UMR 1137, Université Paris Diderot, Paris, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, Paris, France.; Anglaret X; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Programme PACCI, Abidjan, Côte d'Ivoire.; Malvy D; Inserm, UMR 1219, Université de Bordeaux, Bordeaux, France.; Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE